Cancer patients are agreeing to treatment plans lacking a fundamental understanding of the impacts on their finances, explained Ellen Miller Sonet, MBA, JD, chief strategy and policy officer, CancerCare.
Cancer patients are agreeing to treatment plans lacking a fundamental understanding of the impacts on their finances, explained Ellen Miller Sonet, MBA, JD, chief strategy and policy officer, CancerCare.
Transcript
Why is it so important to communicate the financial burden of cancer treatment with patients?
The research that we’ve done suggests that patients don’t know what they’re in for, financially, when they’re making treatment decisions. Consider, for example, buying a car. Would you ever buy a car without knowing the price? Would you buy a refrigerator without knowing the price? Patients are signing on to treatment plans without understanding the financial consequences, and that’s just not right. Both ASCO and the academies of medicine have said that talking about cost is fundamental to shared decision making, high-quality cancer care, and a partnership around doing what’s best for the patient. These kinds of issues have to be explored before treatment decisions are made.
What are best practices for successfully communicating and assisting the patient with these burdens?
The team approach to cancer care is key to making sure that patients really understand the implications of treatment decisions. So, once a physician sees a patient, and they talk about a treatment plan, it’s then really important to sit down and understand how the patient can afford this treatment. We have seen practices where there is a team of navigators, nurses, or financial aid folks that come in and talk to the patients and take them through their co-pays, deductibles, and formulary issues, and help them understand what the impact of treatment will be on their finances.
If that isn’t done, then patients are blind-sided and often suffer the consequences for years. It takes a village. Cancer care is very complex. Patients are overwhelmed with the emotional, physical, spiritual, family, and financial aspects of being sick, and there are many resources that can help support patients on many levels. Patients need to know about them. Providers need to help them understand that these resources exist, and they can make the experience of having cancer less difficult for patients if they know about and avail themselves of these resources.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Reviving the Classics: The Role of Older Medications in Modern Dermatology
March 9th 2025Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost barriers.
Read More
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More